An immunomodulatory photosensitizer-mediated photodynamic therapy synergizes with PD-L1 blockade against metastatic triple-negative breast cancer

The clinical potency of anti-programmed death-ligand 1 (PD-L1) therapy in metastatic triple-negative breast cancer (TNBC) is modest primarily because of the intrinsic low immunogenicity and an immunosuppressive tumor microenvironment (TME). Photodynamic therapy (PDT), an inducer of immunogenic cell...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yuetong Liu, Liming Wang, Feiyan Kong, Tianjun Liu, Hong Liu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-07-01
coleção:	Frontiers in Pharmacology
Assuntos:	photodynamic therapy immunogenic cell death metastatic triple-negative breast cancer programmed death-ligand 1 blockade abscopal effect systemic antitumor immunity
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1651165/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!